← Back to Search

Behavioral Intervention

High-Intensity Gait Training for Stroke

N/A

Waitlist Available

Led By Soo Yeon Sun, PhD

Research Sponsored by Alvernia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

A diagnosis of stroke (intracerebral hemorrhage or acute ischemic stroke)

18 years of age or older

Must not have

Berg Balance Scale (BBS) score ≥ 50/56

Severe spasticity (Modified Ashworth score > 3)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Awards & highlights

Summary

This trial aims to see if making physical therapy sessions more vigorous by keeping participants' heart rates at a certain level through walking practice can improve their walking function and mental health. Researchers will also look at how

Who is the study for?

This trial is for individuals who have had a stroke and are experiencing depression. Participants should be able to undergo vigorous walking exercises aimed at improving their gait and balance. The study seeks people willing to attend 20 physical therapy sessions where their heart rate will be elevated.

What is being tested?

The trial is testing the effectiveness of high-intensity gait training on improving walking function, balance, and mental health in post-stroke patients. It also examines how mental health, social support, and health literacy influence attendance at these sessions.

What are the potential side effects?

While not explicitly mentioned, potential side effects may include muscle soreness, fatigue due to intense exercise, increased heart rate during training, joint discomfort or pain related to physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a stroke.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My balance score is 50 or more out of 56.

Select...

I have severe muscle stiffness.

Select...

I do not have any unstable spine issues or unhealed fractures.

Select...

I have severe joint stiffness in my arms or legs.

Select...

I have an ongoing deep vein clot.

Select...

I cannot walk even with help.

Select...

I have difficulty walking normally due to limited joint movement.

Select...

I can't stand for more than 3 minutes because of pain or dizziness.

Select...

I use a lower limb prosthesis or have had a lower limb amputation.

Select...

I have a colostomy.

Select...

My skin is in poor condition.

Select...

I cannot follow simple instructions.

Select...

I weigh more than 220 pounds.

Select...

I am blind due to a brain condition, not eye damage.

Select...

I am shorter than 5'0" or taller than 6'4".

Select...

I can walk well with minimal assistance.

Select...

I have bone growth in my muscles or tendons that affects my leg movement.

Select...

I do not have severe heart failure (NYHA Class IV).

Select...

My upper leg is over 0.5 inches longer than the other, or my lower leg is over 0.75 inches longer.

Select...

I can't move my ankle upwards when my knee is slightly bent.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

10-meter walk test

3-meter backwards walk test

6-minute walk test

+8 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: High intensity gait trainingExperimental Treatment1 Intervention

Participants will receive 20 sessions of vigorous walking practice. These sessions are 2-3 times a week.

0 / 22Eligibility criteria met

Find a Location

Who is running the clinical trial?

Lehigh Valley Health NetworkUNKNOWN

3 Previous Clinical Trials

8,039 Total Patients Enrolled

Alvernia UniversityLead Sponsor

4 Previous Clinical Trials

198 Total Patients Enrolled

1 Trials studying Stroke

62 Patients Enrolled for Stroke

Soo Yeon Sun, PhDPrincipal InvestigatorAlvernia University

1 Previous Clinical Trials

62 Total Patients Enrolled

1 Trials studying Stroke

62 Patients Enrolled for Stroke

~16 spots leftby Oct 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.